The global immunosuppressants active pharmaceutical ingredients (API) market was valued at approximately $2.15 billion in 2024 and is projected to reach around $2.96 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.08% during the forecast period from
Read more
